Compare · INSP vs SYK
INSP vs SYK
Side-by-side comparison of Inspire Medical Systems Inc. (INSP) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INSP and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $112.48B, about 55.5x INSP ($2.03B).
- Over the past year, INSP is down 12.1% and SYK is down 21.3% - INSP leads by 9.2 points.
- Both names hit the wire about 8 times in the past 4 weeks.
- Both have 25 recent analyst ratings on file.
- Company
- Inspire Medical Systems Inc.
- Stryker Corporation
- Price
- $68.55-2.30%
- $294.69+0.46%
- Market cap
- $2.03B
- $112.48B
- 1M return
- -5.82%
- +5.16%
- 1Y return
- -12.13%
- -21.34%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 8
- 8
- Recent ratings
- 25
- 25
Inspire Medical Systems Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest INSP
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- SEC Form 4 filed by Inspire Medical Systems Inc.
- Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
- Barclays initiated coverage on Inspire Medical Systems with a new price target
- Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
- Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
- Officer Kelly Jason P was granted 6,350 shares, increasing direct ownership by 33% to 25,335 units (SEC Form 4)
- Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Latest SYK
- Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal
- Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery
- Barclays initiated coverage on Stryker with a new price target
- SEC Form 8-K filed by Stryker Corporation
- Stryker announces leadership succession
- Stryker to announce third quarter 2026 financial results
- VP, Chief Financial Officer Wells Preston Wendell disposed of 109 shares, decreasing direct ownership by 3% to 3,661 units (SEC Form 4)
- VP, Chief Financial Officer Wells Preston Wendell disposed of 2,739 shares, decreasing direct ownership by 42% to 3,770 units (SEC Form 4)
- Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
- New insider Baculik Emily Kay claimed ownership of 1,554 shares (SEC Form 3)